Exact Mass: 583.2100588000001
Exact Mass Matches: 583.2100588000001
Found 279 metabolites which its exact mass value is equals to given mass value 583.2100588000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Brigatinib
C29H39ClN7O2P (583.2591233999999)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N-succinyl-chitosan
Pyripyropene A
ITX-5061 free base
C30H37N3O7S (583.2352092000001)
Anthelmycin
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
4-amino-1-[4-amino-O2-(3-amino-beta-D-3-deoxy-glucopyranosyl)-beta-D-glycero-D-galacto-D-gluco-4-deoxy-undecopyranosyl]-1H-pyrimidin-2-one|Hikizimycin
Cys Glu Phe Trp
C28H33N5O7S (583.2100588000001)
Cys Glu Trp Phe
C28H33N5O7S (583.2100588000001)
Cys Phe Glu Trp
C28H33N5O7S (583.2100588000001)
Cys Phe Trp Glu
C28H33N5O7S (583.2100588000001)
Cys Ile Trp Tyr
Cys Ile Tyr Trp
Cys Leu Trp Tyr
Cys Leu Tyr Trp
Cys Trp Glu Phe
C28H33N5O7S (583.2100588000001)
Cys Trp Phe Glu
C28H33N5O7S (583.2100588000001)
Cys Trp Ile Tyr
Cys Trp Leu Tyr
Cys Trp Tyr Ile
Cys Trp Tyr Leu
Cys Tyr Ile Trp
Cys Tyr Leu Trp
Cys Tyr Trp Ile
Cys Tyr Trp Leu
Asp Met Arg Tyr
C24H37N7O8S (583.2424202000001)
Asp Met Tyr Arg
C24H37N7O8S (583.2424202000001)
Asp Arg Met Tyr
C24H37N7O8S (583.2424202000001)
Asp Arg Tyr Met
C24H37N7O8S (583.2424202000001)
Asp Thr Trp Tyr
Asp Thr Tyr Trp
Asp Trp Thr Tyr
Asp Trp Tyr Thr
Asp Tyr Met Arg
C24H37N7O8S (583.2424202000001)
Asp Tyr Arg Met
C24H37N7O8S (583.2424202000001)
Asp Tyr Thr Trp
Asp Tyr Trp Thr
Glu Cys Phe Trp
C28H33N5O7S (583.2100588000001)
Glu Cys Trp Phe
C28H33N5O7S (583.2100588000001)
Glu Phe Cys Trp
C28H33N5O7S (583.2100588000001)
Glu Phe Trp Cys
C28H33N5O7S (583.2100588000001)
Glu Ser Trp Tyr
Glu Ser Tyr Trp
Glu Trp Cys Phe
C28H33N5O7S (583.2100588000001)
Glu Trp Phe Cys
C28H33N5O7S (583.2100588000001)
Glu Trp Ser Tyr
Glu Trp Tyr Ser
Glu Tyr Ser Trp
Glu Tyr Trp Ser
Phe Cys Glu Trp
C28H33N5O7S (583.2100588000001)
Phe Cys Trp Glu
C28H33N5O7S (583.2100588000001)
Phe Glu Cys Trp
C28H33N5O7S (583.2100588000001)
Phe Glu Trp Cys
C28H33N5O7S (583.2100588000001)
Phe Met Thr Trp
Phe Met Trp Thr
Phe Thr Met Trp
Phe Thr Trp Met
Phe Trp Cys Glu
C28H33N5O7S (583.2100588000001)
Phe Trp Glu Cys
C28H33N5O7S (583.2100588000001)
Phe Trp Met Thr
Phe Trp Thr Met
His His Gln Tyr
His His Tyr Gln
His Asn Gln Trp
His Asn Trp Gln
His Gln His Tyr
His Gln Asn Trp
His Gln Trp Asn
His Gln Tyr His
His Trp Asn Gln
His Trp Gln Asn
His Tyr His Gln
His Tyr Gln His
Ile Cys Trp Tyr
Ile Cys Tyr Trp
Ile Trp Cys Tyr
Ile Trp Tyr Cys
Ile Tyr Cys Trp
Ile Tyr Trp Cys
Leu Cys Trp Tyr
Leu Cys Tyr Trp
Leu Trp Cys Tyr
Leu Trp Tyr Cys
Leu Tyr Cys Trp
Leu Tyr Trp Cys
Met Asp Arg Tyr
C24H37N7O8S (583.2424202000001)
Met Asp Tyr Arg
C24H37N7O8S (583.2424202000001)
Met Phe Thr Trp
Met Phe Trp Thr
Met Arg Asp Tyr
C24H37N7O8S (583.2424202000001)
Met Arg Tyr Asp
C24H37N7O8S (583.2424202000001)
Met Thr Phe Trp
Met Thr Trp Phe
Met Trp Phe Thr
Met Trp Thr Phe
Met Tyr Asp Arg
C24H37N7O8S (583.2424202000001)
Met Tyr Arg Asp
C24H37N7O8S (583.2424202000001)
Asn His Gln Trp
Asn His Trp Gln
Asn Gln His Trp
Asn Gln Trp His
Asn Trp His Gln
Asn Trp Gln His
Gln His His Tyr
Gln His Asn Trp
Gln His Trp Asn
Gln His Tyr His
Gln Asn His Trp
Gln Asn Trp His
Gln Trp His Asn
Gln Trp Asn His
Gln Tyr His His
Arg Asp Met Tyr
C24H37N7O8S (583.2424202000001)
Arg Asp Tyr Met
C24H37N7O8S (583.2424202000001)
Arg Met Asp Tyr
C24H37N7O8S (583.2424202000001)
Arg Met Tyr Asp
C24H37N7O8S (583.2424202000001)
Arg Tyr Asp Met
C24H37N7O8S (583.2424202000001)
Arg Tyr Met Asp
C24H37N7O8S (583.2424202000001)
Ser Glu Trp Tyr
Ser Glu Tyr Trp
Ser Trp Glu Tyr
Ser Trp Tyr Glu
Ser Tyr Glu Trp
Ser Tyr Trp Glu
Thr Asp Trp Tyr
Thr Asp Tyr Trp
Thr Phe Met Trp
Thr Phe Trp Met
Thr Met Phe Trp
Thr Met Trp Phe
Thr Trp Asp Tyr
Thr Trp Phe Met
Thr Trp Met Phe
Thr Trp Tyr Asp
Thr Tyr Asp Trp
Thr Tyr Trp Asp
Trp Cys Glu Phe
C28H33N5O7S (583.2100588000001)
Trp Cys Phe Glu
C28H33N5O7S (583.2100588000001)
Trp Cys Ile Tyr
Trp Cys Leu Tyr
Trp Cys Tyr Ile
Trp Cys Tyr Leu
Trp Asp Thr Tyr
Trp Asp Tyr Thr
Trp Glu Cys Phe
C28H33N5O7S (583.2100588000001)
Trp Glu Phe Cys
C28H33N5O7S (583.2100588000001)
Trp Glu Ser Tyr
Trp Glu Tyr Ser
Trp Phe Cys Glu
C28H33N5O7S (583.2100588000001)
Trp Phe Glu Cys
C28H33N5O7S (583.2100588000001)
Trp Phe Met Thr
Trp Phe Thr Met
Trp His Asn Gln
Trp His Gln Asn
Trp Ile Cys Tyr
Trp Ile Tyr Cys
Trp Leu Cys Tyr
Trp Leu Tyr Cys
Trp Met Phe Thr
Trp Met Thr Phe
Trp Asn His Gln
Trp Asn Gln His
Trp Gln His Asn
Trp Gln Asn His
Trp Ser Glu Tyr
Trp Ser Tyr Glu
Trp Thr Asp Tyr
Trp Thr Phe Met
Trp Thr Met Phe
Trp Thr Tyr Asp
Trp Tyr Cys Ile
Trp Tyr Cys Leu
Trp Tyr Asp Thr
Trp Tyr Glu Ser
Trp Tyr Ile Cys
Trp Tyr Leu Cys
Trp Tyr Ser Glu
Trp Tyr Thr Asp
Tyr Cys Ile Trp
Tyr Cys Leu Trp
Tyr Cys Trp Ile
Tyr Cys Trp Leu
Tyr Asp Met Arg
C24H37N7O8S (583.2424202000001)
Tyr Asp Arg Met
C24H37N7O8S (583.2424202000001)
Tyr Asp Thr Trp
Tyr Asp Trp Thr
Tyr Glu Ser Trp
Tyr Glu Trp Ser
Tyr His His Gln
Tyr His Gln His
Tyr Ile Cys Trp
Tyr Ile Trp Cys
Tyr Leu Cys Trp
Tyr Leu Trp Cys
Tyr Met Asp Arg
C24H37N7O8S (583.2424202000001)
Tyr Met Arg Asp
C24H37N7O8S (583.2424202000001)
Tyr Gln His His
Tyr Arg Asp Met
C24H37N7O8S (583.2424202000001)
Tyr Arg Met Asp
C24H37N7O8S (583.2424202000001)
Tyr Ser Glu Trp
Tyr Ser Trp Glu
Tyr Thr Asp Trp
Tyr Thr Trp Asp
Tyr Trp Cys Ile
Tyr Trp Cys Leu
Tyr Trp Asp Thr
Tyr Trp Glu Ser
Tyr Trp Ile Cys
Tyr Trp Leu Cys
Tyr Trp Ser Glu
Tyr Trp Thr Asp
(3R,4S)-tert-Butyl 3-(bis(4-Methoxyphenyl)(phenyl)Methoxy)-4-((Methylsulfonyl)oxy)pyrrolidine-1-carboxylate
Nilotinib hydrochloride monohydrate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor
Pyripyropene A
A sesquiterpenoid that consists of (3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-(acetoxymethyl)-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromene-3,6-diol in which the hydrogens of the 3- and 6-hydroxy functions are substituted by acetyl groups.
methyl (phenyl 5-acetamido-4,7,8,9-tetra-o-acetyl-3,5-dideoxy-2-thio-d-glycero-d-galacto-2-nonulopyranosid)onate
C26H33NO12S (583.1723378000002)
4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7- oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1- piperazinecarboxylic acid 1,1-dimethylethyl ester
Methyl 2-[(2-methylpyridin-4-yl)methyl]-1-oxo-8-(pyrimidin-2-ylmethoxy)-4-(3,4,5-trimethoxyphenyl)-1,2-dihydro-2,7-naphthyridine-3-carboxylate
C31H29N5O7 (583.2066884000001)
Brigatinib
C29H39ClN7O2P (583.2591233999999)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-gammaGlu-L-gammaGlu-OH
C25H29N9O8 (583.2138994000001)
1-[5-[3-Amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]pyrrolidine-2,5-dione
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N,4-dimethylbenzenesulfonamide
C29H33N3O6S2 (583.1810678000002)
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N,4-dimethylbenzenesulfonamide
C29H33N3O6S2 (583.1810678000002)
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N,4-dimethylbenzenesulfonamide
C29H33N3O6S2 (583.1810678000002)
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N,4-dimethylbenzenesulfonamide
C29H33N3O6S2 (583.1810678000002)
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N,4-dimethylbenzenesulfonamide
C29H33N3O6S2 (583.1810678000002)
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N,4-dimethylbenzenesulfonamide
C29H33N3O6S2 (583.1810678000002)
2-[(2R,4aS,12aS)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N,4-dimethylbenzenesulfonamide
C29H33N3O6S2 (583.1810678000002)
2-[(2S,4aS,12aR)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(2R,4aS,12aR)-8-[(4-chlorophenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-piperidin-1-ylethyl)acetamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N,4-dimethylbenzenesulfonamide
C29H33N3O6S2 (583.1810678000002)
2-[(2S,4aR,12aS)-8-[(4-chlorophenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-piperidin-1-ylethyl)acetamide
2-[(2S,4aR,12aR)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
C30H37N3O7S (583.2352092000001)
1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
C30H37N3O7S (583.2352092000001)
2-[(2S,4aS,12aS)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
1-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
C30H37N3O7S (583.2352092000001)
1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
C30H37N3O7S (583.2352092000001)
1-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
C30H37N3O7S (583.2352092000001)
1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
C30H37N3O7S (583.2352092000001)
1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
C30H37N3O7S (583.2352092000001)
1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
C30H37N3O7S (583.2352092000001)
2-[(2R,4aR,12aR)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(2R,4aR,12aS)-8-[[(4-chloroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
Antelmycin
A nucleoside antibiotic with anthelminthic properties that is isolated from Streptomyces longissimus.
12-ethyl-8-propyl-3-vinylbacteriochlorophyllide d(1-)
A cyclic tetrapyrrole anion that is the conjugate base of 12-ethyl-8-propyl-3-vinylbacteriochlorophyllide d, obtained by deprotonation of the carboxy group; major species at pH 7.3.
ASTX029
ASTX029 (Example 1) is a potent dual ERK1/2 inhibitor (IC50: 2.7 nM). ASTX029 has anti-cancer activity[1][2].
AZD-8529 (mesylate)
AZD-8529 mesylate is a potent, highly selective and orally bioavailable positive allosteric modulator of mGluR2, with an EC50 of 285 nM, and shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes[1].